COLOR II: Laparoscopic Versus Open Rectal Cancer Removal

PHASE3CompletedINTERVENTIONAL
Enrollment

1,044

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

April 30, 2013

Study Completion Date

September 30, 2015

Conditions
Rectal Cancer
Interventions
PROCEDURE

surgery

randomized to open or laparoscopic technique

Trial Locations (35)

Unknown

Universitair Ziekenjuis Leuven, Leuven

Royal Alexandra Hospital, University of Alberta, Edmonton

University of Western Ontario, London

Aalborg Hospital, Aalborg

SVS Esbjerg, Esbjerg

Amtssygehus i Gentofte, Gentofte Municipality

Hilleröd Hospital, Hilleröd

Odense Universitetshospital, Odense

Roskilde Hospital, Roskilde

Viborg, Viborg

Ludwig-Maximilians Universität Klinikum Großhadern, München

Caritas-Krankenhaus St. Josef, Regensburg

University Hospital Regensburg, Regensburg

Marienhospital, Stuttgart

Wuerzburg University, Würzburg

Jeroen Bosch Ziekenhuis, 's-Hertogenbosch

Academisch Medisch Centrum, Amsterdam

Onze Lieve Vrouwe Gasthuis, Amsterdam

VU Medisch Centrum, Amsterdam

Rijnland Ziekenhuis, Leiderdorp

Erasmus Medical Centre, Rotterdam

Medisch Centrum Rijnmond-Zuid, Rotterdam

Jagiellonian University, Krakow

Korea University Anam Hospital, Seoul

Hospital Clinic i Provencial de Barcelona, Barcelona

Hospital de Sant Pau, Barcelona

Hospital S.A.S. de Jerez, Cadiz

Hospital del Sureste de Madrid, Madrid

Arrixaca Hospital Universitario, Murcia

Sahlgrenska University Hospital, Gothenburg

Örebro Hospital, Örebro

Kärnsjukhuset, Skvöde

Ersta Hospital, Stockholm

Uddevalla Hospital, Uddevalla

B3H 2Y9

CDHA/ Dalhousie University, Halifax

All Listed Sponsors
lead

Nova Scotia Health Authority

OTHER

NCT00297791 - COLOR II: Laparoscopic Versus Open Rectal Cancer Removal | Biotech Hunter | Biotech Hunter